Status:

UNKNOWN

Detection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic Disease

Lead Sponsor:

National Taiwan University Hospital

Collaborating Sponsors:

National Science and Technology Council, Taiwan

Conditions:

Trophoblastic Neoplasms

Eligibility:

FEMALE

20-50 years

Brief Summary

We will try to use the novel analytical technique -Dual Polarisation Interferometry (DPI),to achieve detection the minimal amount of the human chorionic gonadotropin for early detection and strict mon...

Detailed Description

1 Gestational trophoblastic disease (GTD) consists of a spectrum of disorders that are characterized by an abnormal proliferation of trophoblastic tissue. They include hydatidiform mole, invasive mole...

Eligibility Criteria

Inclusion

  • Hydatidiform Mole
  • Choriocarcinoma
  • Gestational Trophoblastic Neoplasms

Exclusion

  • Unwilling to participate in the study

Key Trial Info

Start Date :

September 1 2005

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2014

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00166790

Start Date

September 1 2005

End Date

December 1 2014

Last Update

December 8 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Taiwan University Hospital Department of Obstetrics and Gynecology

Taipei, Taipei, Taiwan, 100

Detection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic Disease | DecenTrialz